Synboli is a materials science company that accelerates polymer discovery by combining AI-powered design with patented chemical synthesis to deliver novel, high-performance materials for industries such as pharma, electronics, and transportation.
Synboli is a materials science company that specializes in accelerating the discovery and development of high-performance polymers. The company utilizes a proprietary platform that integrates artificial intelligence with patented chemical synthesis technology. By building high-quality, application-specific databases and leveraging specialized AI models, Synboli can predict novel polymer structures, produce lab-scale samples for validation, and facilitate industrial scale-up. This approach allows the company to reduce the timeline for discovering new materials from years to mere months, enabling access to previously unknown chemical structures.
This technology addresses critical material challenges for industries including pharmaceuticals, electronics, and transportation. Synboli collaborates with partners to develop tailored solutions, such as optimizing polymers for advanced drug delivery, improving thermal management in electronics, and creating lightweight, durable materials for mobility. Born from innovation at the CNRS and the University of Bordeaux, the company supports its mission through a combination of in-silico prediction and in-laboratory evaluation, helping clients achieve faster time-to-market and enhanced product performance.